Atea Pharmaceuticals (AVIR) Return on Equity [ROE] (2020 - 2026)
Atea Pharmaceuticals (AVIR) posted Return on Equity [ROE] of -75.50% for Q2 2026, down 40.39 percentage points from -35.11% a year earlier and down 8.91 percentage points from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Atea Pharmaceuticals' Return on Equity [ROE] came in at -44.34%, down 10.46 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -39.94 percentage points (FY2020 to FY2025).
- In prior years, Atea Pharmaceuticals' Return on Equity [ROE] was -33.88% in FY2024 (-11.14 pp), -22.74% in FY2023 (-5.58 pp), -17.16% in FY2022 (-36.43 pp) and 19.27% in FY2021 (+23.66 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -15.75 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 23.41 percentage points; the weakest was Q2 2026, with a drop of 40.39 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -66.59% (Q1 2026), -53.57% (Q4 2025) and -43.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Atea Pharmaceuticals | 417.87 Mn | 417.87 Mn | - | -75.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.50% |
| Mar 31, 2026 | -66.59% |
| Dec 31, 2025 | -53.57% |
| Sep 30, 2025 | -43.23% |
| Jun 30, 2025 | -35.11% |
| Mar 31, 2025 | -32.82% |
| Dec 31, 2024 | -37.53% |
| Sep 30, 2024 | -37.22% |
| Jun 30, 2024 | -35.89% |
| Mar 31, 2024 | -30.89% |
| Dec 31, 2023 | -23.92% |
| Sep 30, 2023 | -22.16% |
| Jun 30, 2023 | -17.39% |
| Mar 31, 2023 | -17.37% |
| Dec 31, 2022 | -17.78% |
| Sep 30, 2022 | 5.39% |
| Jun 30, 2022 | 2.32% |
| Mar 31, 2022 | 6.96% |
| Dec 31, 2021 | 18.77% |
| Sep 30, 2021 | 4.19% |
API Access
Atea Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();